Although the issues surrounding gadolinium’s presence in contrasting agents for MRI’s and MRA’s has been in the news in one form or another for quite some time, now comes word that medical publications are beginning to take notice. The latest example was published on eMaxHealth.com, a widely-read health-driven newsletter, which published a story regarding the problems that have been linked to gadolinium.“A painful and debilitating condition that affects patients with kidney failure may be more common than previously believed and appears to be strongly associated with prior exposure to certain contrast agents used in imaging studies.
In addition, individuals with this syndrome - called nephrogenic systemic fibrosis (NSF) - appear to have a significantly increased risk of dying. The findings from Massachusetts General Hospital (MGH) investigators appear in the October issue of the journal Arthritis & Rheumatism.”Obviously, the word regarding gadolinium is spreading, and hopefully this will help prevent future problems. If you have been injured as a result of having gadolinium injected into your system, contact the gadolinium lawyers at Williams Kherkher for a free consultation either by using the link provided or by calling (866) 950-9000.
1 response so far ↓
1 Sandra // Oct 11, 2007 at 8:49 pm
Is there a safer alternative contrast agent that can be used in MRI studies?
Leave a Comment